Palmitoyl acyltransferase assays and inhibitors (Review)
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Palmitoylated proteins have been implicated in several disease states including Huntington's, cardiovascular, T-cell mediated immune diseases, and cancer. To proceed with drug discovery efforts in this area, it is necessary to: identify the target enzymes, establish efficient assays for palmitoylation, and conduct high-throughput screening to identify inhibitors. The primary objectives of this review are to examine the types of assays used to study protein palmitoylation and to discuss the known inhibitors of palmitoylation. Six main palmitoylation assays are currently in use. Four assays, radiolabeled palmitate incorporation, fatty acyl exchange chemistry, MALDI-TOF MS and azido-fatty acid labeling are useful in the identification of palmitoylated proteins and palmitoyl acyltransferase (PAT) enzymes. Two other methods, the in vitro palmitoylation (IVP) assay and a cell-based peptide palmitoylation assay, are useful in the identification of PAT enzymes and are more amenable to screening for inhibitors of palmitoylation. To date, two general types of palmitoylation inhibitors have been identified. Lipid-based palmitoylation inhibitors broadly inhibit the palmitoylation of proteins; however, the mechanism of action of these compounds is unknown, and each also has effects on fatty acid biosynthesis. Conversely, several non-lipid palmitoylation inhibitors have been shown to selectively inhibit the palmitoylation of different PAT recognition motifs. The selective nature of these compounds suggests that they may act as protein substrate competitors, and may produce fewer non-specific effects. Therefore, these molecules may serve as lead compounds for the further development of selective inhibitors of palmitoylation, which may lead to new therapeutics for cancer and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, X., Nazarian, A., Erdjument-Bromage, H., Bornmann, W., Tempst, P., & Resh, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104018200 · Cited by 227 · cited 1×
“Also, this method of analysis provides the investigator with the exact mass of the modifying group, and allows the identification of novel palmitoylated proteins [15,22].”
Method
Cited by
The Physiology of Protein S-acylation
Chamberlain, L. H., & Shipston, M. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00032.2014 · Cited by 406
Inhibition of Ras for Cancer Treatment: The Search Continues
Baines, A. T., Xu, D., & Der, C. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.121 · Cited by 382
Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice
Ni, H., Wang, Y., Yao, K., Wang, L., Huang, J., Xiao, Y., Chen, H., Liu, B., Yang, C. Y., & Zhao, J. (2024) · Nature Communications · doi:10.1038/s41467-023-43650-z · Cited by 281
McCarthy, M., & Raval, A. P. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01998-9 · Cited by 254
Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts
Bhattacharyya, R., Barren, C., & Kovacs, D. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4704-12.2013 · Cited by 171
Metadata
- Authors
- Draper, J. M., & Smith, C. D.
- Venue
- Molecular Membrane Biology
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 26
- Issue
- 1-2
- Pages
- 5-13
- ISSN
- 0968-7688 (ISSN-L)
- 1464-5203
- OpenAlex
- W2028824717
- Cited by
- 79
- References
- 1
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Palmitoyl acyltransferase assays and inhibitors (Review). https://app.cochat.ai/papers/10.1080/09687680802683839
- The paper
- Draper, J. M., & Smith, C. D. (2009). Palmitoyl acyltransferase assays and inhibitors (Review). Molecular Membrane Biology. https://doi.org/10.1080/09687680802683839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.